Skip to main content
. 2013 Mar 28;13:8. doi: 10.1186/1471-2482-13-8

Table 1.

Patients’ characteristics according to each remission category

Variable
 
2009 Consensus group criteria (Model 1)
 
ADA’s HbA1c criteria (Model 2)
 
    TOTAL Complete Partial No remission p <5.7% 5.7-6.5% >6.5% and/or treatment p
No of patients
 
110
55 (50.0)
14 (12.7)
41 (37.3)
 
55 (50.0)
17 (15.5)
38 (34.5)
 
Age (years)
 
53.3 ± 9.5
51.5 ± 9.8
55.6 ± 8.0
54.9 ± 9.4
0.230
52.1 ± 9.7
52.8 ± 8.4
55.2 ± 9.7
0.299
Preop - BMI (kg/m2)
 
43.6 ± 5.5
44.3 ± 5.2
43.7 ± 4.8
42.8 ± 6.0
0.514
44.1 ± 4.9
43.6 ± 6.2
43.0 ± 6.0
0.595
18 m - BMI (kg/m2)
 
29.0 ± 5.0
28.1 ± 4.5
31.8 ± 4.9
29.2 ± 5.4
0.049
28.3 ± 4.3
30.9 ± 6.0
29.3 ± 5.4
0.193
Preop – FG (mg/dl)
 
165.2 ± 58.5
156.0 ± 55.3
137.8 ± 26.6
186.9 ± 64.3
0.004
153.9 ± 55.1
142.0 ± 29.5
191.8 ± 64.4
0.001
18 m – FG (mg/dl)
 
100.2 ± 23.9
86.7 ± 7.5
104.6 ± 6.9
118.6 ± 30.4
0.000
87.7 ± 8.9
101.5 ± 12.4
119.8 ± 30.8
0.000
Preop - HbA1c (%)
 
7.9 ± 1.8
7.5 ± 1.5
7.0 ± 0.8
8.6 ± 1.9
0.002
7.3 ± 1.3
7.7 ± 1.8
8.7 ± 1.9
0.000
18 m - HbA1c (%)
 
5.4 ± 0.7
5.0 ± 0.6
5.5 ± 0.5
6.1 ± 0.6
0.000
4.9 ± 0.5
5.8 ± 0.1
6.1 ± 0.7
0.000
%WL
 
33.1 ± 9.4
36.1 ± 7.9
27.1 ± 7.2
31.0 ± 10.4
0.001
35.6 ± 8.1
29.4 ± 8.3
31.0 ± 10.5
0.014
%EWL
 
70.7 ± 21.0
75.9 ± 17.7
57.0 ± 15.3
68.6 ± 24.4
0.007
74.9 ± 17.7
63.3 ± 22.5
68.0 ± 23.7
0.070
Duration of diabetes (years)
 
7.6 ± 7.5
5.1 ± 4.0
4.4 ± 4.8
11.9 ± 9.9
0.001
5.3 ± 4.3
4.6 ± 3.5
12.6 ± 10.0
0.000
Previous treatment with insulin
No
61 (55.5)
39 (70.9)
10 (71.4)
12 (29..3)
0.000
37 (67.3)
14 (82.4)
10 (26.3)
0.000
  Yes 49 (44.5) 16 (29.1) 4 (28.6) 29 (70.7)   18 (32.7) 3 (17.6) 28/73.7)  

Values show mean ± SD or number of patients and percentages (%).

“Preop” = preoperative; “18 m” = 18-month; “BMI” = body mass index; “FG” = fasting glucose; “HbA1c” = glycosylated hemoglobin; “%WL” = percentage body weight loss at 18 months; “%EWL” = percentage excess body weight loss at 18 months.